Biophore receives sub-license from MPP to manufacture and market molnupiravir for COVID treatment
Hyderabad, 20 January 2022: Biophore India Pharmaceuticals has announced that it has received a license from Medicines Patent Pool (MPP)...
Hyderabad, 20 January 2022: Biophore India Pharmaceuticals has announced that it has received a license from Medicines Patent Pool (MPP)...